Sabrina Mastroianni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sabrina Mastroianni has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Abhilekh Srivastava
Department of Medicine, Division of Neurology, Mcmaster University, Hamilton, Ontario, Canada
1 shared publication - Anagha Vinod
Department of Psychology, Neuroscience & Behaviour, McMaster University, Hamilton, ON L8S 4L8, Canada
1 shared publication - Areti Angeliki Veroniki
Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Center for Evidence Synthesis in Health, Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island, USA
1 shared publication - Aristeidis H. Katsanos
Division of Neurology, McMaster University and Population Health Research Institute, Hamilton, ON, Canada
1 shared publication - Ashkan Shoamanesh
Department of Medicine (Neurology), Population Health Research Institute, McMaster University, Hamilton, ON, Canada 1
1 shared publication - Dimitrios Deris
Department of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada
1 shared publication
Latest Publications
- Open Access
- 5 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (17) , 6268
Performance of Stratification Scores on the Risk of Stroke After a Transient Ischemic Attack: A Systematic Review and Network Meta-Analysis
Background: Patients after a transient ischemic attack (TIA) are at high risk of subsequent stroke. There are various scores that aim to accurately identify patients at the highest risk of stroke. However, without comparisons between these scores, it is still unknown which is the score with the best predictive utility. Our study aims to identify the risk stratification score with the highest utility to identify patients at high risk for stroke within 90 days after a TIA. Methods: The MEDLINE and Scopus databases were systematically searched on 1 December 2023 for observational cohort studies assessing the ability of a score to predict a stroke within the first 90 days from the index TIA event. Only studies that had a direct comparison of at least two scores were included. A random-effects network meta-analysis was performed. Sensitivity and specificity, along with relevant 95% credible intervals, and between-score and between-study heterogeneity were estimated. We also estimated relative sensitivities and relative specificities compared with the ABCD2 score. We ranked each score according to its predictive accuracy based on both sensitivity and specificity estimates, using the diagnostic odds ratio (DOR) and the summary receiver operating characteristic (SROC) curve. Results: Our systematic review highlighted 9 studies including 14 discrete cohorts. The performance of all scores to identify patients at high risk for stroke recurrence within 90 days following a TIA was low (pooled sensitivity range 48–64%, pooled specificity range 59–72%). In the network meta-analysis, we analyzed 6 studies with 11 discrete cohorts, including data from 8217 patients. The ABCD3-I score demonstrated the highest DOR, followed by the ESRS, ABCD, California, and ABCD2. The SROC curves demonstrate no significant differences in the performance of the scores, using the ABCD score as the common comparator. Conclusions: In this systematic review and network meta-analysis of observational cohort studies of patients who experienced TIA and were followed for the occurrence of subsequent stroke, we failed to identify a score performing significantly better for the prediction of stroke at 90 days. New models are needed for the prediction and stroke risk stratification following a TIA.
- 5 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (17) , 6268
Open AccessPerformance of Stratification Scores on the Risk of Stroke After a Transient Ischemic Attack: A Systematic Review and Network Meta-Analysis
Background: Patients after a transient ischemic attack (TIA) are at high risk of subsequent stroke. There are various scores that aim to accurately identify patients at the highest risk of stroke. However, without comparisons between these scores, it is still unknown which is the score with the best predictive utility. Our study aims to identify the risk stratification score with the highest utility to identify patients at high risk for stroke within 90 days after a TIA. Methods: The MEDLINE and Scopus databases were systematically searched on 1 December 2023 for observational cohort studies assessing the ability of a score to predict a stroke within the first 90 days from the index TIA event. Only studies that had a direct comparison of at least two scores were included. A random-effects network meta-analysis was performed. Sensitivity and specificity, along with relevant 95% credible intervals, and between-score and between-study heterogeneity were estimated. We also estimated relative sensitivities and relative specificities compared with the ABCD2 score. We ranked each score according to its predictive accuracy based on both sensitivity and specificity estimates, using the diagnostic odds ratio (DOR) and the summary receiver operating characteristic (SROC) curve. Results: Our systematic review highlighted 9 studies including 14 discrete cohorts. The performance of all scores to identify patients at high risk for stroke recurrence within 90 days following a TIA was low (pooled sensitivity range 48–64%, pooled specificity range 59–72%). In the network meta-analysis, we analyzed 6 studies with 11 discrete cohorts, including data from 8217 patients. The ABCD3-I score demonstrated the highest DOR, followed by the ESRS, ABCD, California, and ABCD2. The SROC curves demonstrate no significant differences in the performance of the scores, using the ABCD score as the common comparator. Conclusions: In this systematic review and network meta-analysis of observational cohort studies of patients who experienced TIA and were followed for the occurrence of subsequent stroke, we failed to identify a score performing significantly better for the prediction of stroke at 90 days. New models are needed for the prediction and stroke risk stratification following a TIA.
- Open Access
Derivation of Novel Imaging Biomarkers of Neonatal Brain Injury Using Bedside Diffuse Optical Tomography: Protocol for a Prospective Feasibility Study
Prognostication of neurodevelopmental outcomes for neonates with hypoxic–ischemic encephalopathy (HIE) is primarily reliant on structural assessment using conventional brain magnetic resonance imaging in the clinical setting. Diffuse optical tomography (DOT) can provide complementary information on brain function at the bedside, further enhancing prognostic accuracy. The predictive accuracy and generalizability of DOT-based neuroimaging markers are unknown. This study aims to test the feasibility of prospectively recruiting and retaining neonates for 12 months in a larger study that investigates the prognostic utility of DOT-based biomarkers of HIE. The study will recruit 25 neonates with HIE over one year and follow them beyond NICU discharge at 6 and 12 months of age. Study subjects will undergo resting-state DOT measurement within 7 days of life for a 30–45-min period without sedation. A customized neonatal cap with 10 sources and eight detectors per side will be used to quantify cortical functional connectivity and to generate brain networks using MATLAB-based software (version 24.2). The Ages and Stages Questionnaires—3rd edition will be used for standardized developmental assessments at follow-up. This feasibility study will help refine the design and sample-size calculation for an adequately powered larger study that determines the clinical utility of DOT-based neuroimaging in perinatal brain injury.
Open AccessDerivation of Novel Imaging Biomarkers of Neonatal Brain Injury Using Bedside Diffuse Optical Tomography: Protocol for a Prospective Feasibility Study
Prognostication of neurodevelopmental outcomes for neonates with hypoxic–ischemic encephalopathy (HIE) is primarily reliant on structural assessment using conventional brain magnetic resonance imaging in the clinical setting. Diffuse optical tomography (DOT) can provide complementary information on brain function at the bedside, further enhancing prognostic accuracy. The predictive accuracy and generalizability of DOT-based neuroimaging markers are unknown. This study aims to test the feasibility of prospectively recruiting and retaining neonates for 12 months in a larger study that investigates the prognostic utility of DOT-based biomarkers of HIE. The study will recruit 25 neonates with HIE over one year and follow them beyond NICU discharge at 6 and 12 months of age. Study subjects will undergo resting-state DOT measurement within 7 days of life for a 30–45-min period without sedation. A customized neonatal cap with 10 sources and eight detectors per side will be used to quantify cortical functional connectivity and to generate brain networks using MATLAB-based software (version 24.2). The Ages and Stages Questionnaires—3rd edition will be used for standardized developmental assessments at follow-up. This feasibility study will help refine the design and sample-size calculation for an adequately powered larger study that determines the clinical utility of DOT-based neuroimaging in perinatal brain injury.